ENTITY
BeiGene

BeiGene (6160 HK)

301
Analysis
Health CareChina
BeiGene, Ltd. operates as a commercial stage biopharmaceutical company. The Company focuses on discovery, development, and commercialization of molecularly targeted and immuno-oncology drugs for the treatment of cancer. BeiGene serves patients worldwide.
more
Refresh
Exchange Announcement05 Jul 2024 16:41
Exchange Announcement03 Jul 2024 17:06
Exchange Announcement02 Jul 2024 08:03
Exchange Announcement24 Jun 2024 08:00
x